Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells.

Resident macrophages in the liver (Kupffer cells) produce various cytokines and chemokines, and have important roles in hepatitis and liver fibrosis. The cells are activated by various factors, for example lipopolysaccharide (LPS), which is an endotoxin and is high in the blood of patients with liver cirrhosis. Involvement of P2 receptors in the release of pro-inflammatory cytokines from Kupffer cells is little. In this study, we investigated purinergic signaling in the release of pro-inflammatory cytokines, such as IL-6 and TNF-α, from liver Kupffer cells of C57BL/6 mice (KUP5 cells). KUP5cells were isolated from C57BL/6 mice and cultivated with Dulbecco's modified Eagle's medium. The cells were stimulated with LPS. LPS-induced IL-6 production by KUP5 cells was suppressed significantly by pretreatments with non-selective P2 antagonist suramin, P2Y13antagonist MRS2211, and ecto-nucleotidase, whereas P2Y receptor agonists, significantly increased the IL-6 production. P2Y13knockdown reduced LPS-induced IL-6 production, but by less than 50%. These results would suggest that P2Y receptors including P2Y13and others, may involves in LPS-induced IL-6 production in Kupffer cells, leading to the liver inflammation. Therefore, we first showed the importance of purinergic signaling via P2Y receptors in the activation of Kupffer cells and liver injury, which is worthwhile in drug development for liver diseases.

[1]  Y. Moriyama,et al.  Autocrine Regulation of Macrophage Activation via Exocytosis of ATP and Activation of P2Y11 Receptor , 2013, PloS one.

[2]  M. Tsukimoto,et al.  Involvement of P2Y₁₁ receptor in IFN-γ-induced IL-6 production in human keratinocytes. , 2013, European journal of pharmacology.

[3]  F. Di Virgilio,et al.  Purinergic P2Y₂ receptors promote neutrophil infiltration and hepatocyte death in mice with acute liver injury. , 2012, Gastroenterology.

[4]  G. Burnstock,et al.  Pathological roles of purinergic signaling in the liver. , 2012, Journal of hepatology.

[5]  T. Takenouchi,et al.  Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. , 2012, Biochemical and biophysical research communications.

[6]  S. Robson,et al.  Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia , 2011, Purinergic Signalling.

[7]  M. Yoshioka,et al.  A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells , 2011, Journal of visualized experiments : JoVE.

[8]  D. Candinas,et al.  Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice , 2010, Hepatology.

[9]  S. Robson,et al.  SP1-Dependent Induction of CD39 Facilitates Hepatic Ischemic Preconditioning , 2010, The Journal of Immunology.

[10]  P. Insel,et al.  Basal Release of ATP: An Autocrine-Paracrine Mechanism for Cell Regulation , 2010, Science Signaling.

[11]  D. Candinas,et al.  Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. , 2008, Gastroenterology.

[12]  Keisuke Sawada,et al.  Identification of a vesicular nucleotide transporter , 2008, Proceedings of the National Academy of Sciences.

[13]  G. Kolios,et al.  Role of Kupffer cells in the pathogenesis of liver disease. , 2006, World journal of gastroenterology.

[14]  Eric A. Barnard,et al.  International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy , 2006, Pharmacological Reviews.

[15]  F. Di Virgilio,et al.  A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. , 2005, Molecular biology of the cell.

[16]  J. Boeynaems,et al.  Pharmacological characterization of the human P2Y13 receptor. , 2003, Molecular pharmacology.

[17]  G. Droogmans,et al.  Volume-regulated Anion Channels Serve as an Auto/Paracrine Nucleotide Release Pathway in Aortic Endothelial Cells , 2002, The Journal of general physiology.

[18]  C. Naus,et al.  Intercellular Calcium Signaling in Astrocytes via ATP Release through Connexin Hemichannels* , 2002, The Journal of Biological Chemistry.

[19]  M. L. Ellsworth,et al.  Deformation-induced ATP release from red blood cells requires CFTR activity. , 1998, American journal of physiology. Heart and circulatory physiology.

[20]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[21]  Marc Parmentier,et al.  Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase* , 1997, The Journal of Biological Chemistry.

[22]  G. Burnstock.  The past, present and future of purine nucleotides as signalling molecules , 1997, Neuropharmacology.

[23]  S. Opal,et al.  Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection , 1997, The Journal of experimental medicine.

[24]  R. Wilson,et al.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.

[25]  M. Czaja,et al.  Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. , 1995, Gastroenterology.

[26]  M. Jordana,et al.  Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. , 1994, Journal of immunology.

[27]  A. Husband,et al.  The role of interleukin-6 in mucosal IgA antibody responses in vivo. , 1994, Science.

[28]  B. Barton,et al.  Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model , 1993, Infection and immunity.

[29]  D. Laskin,et al.  Characterization of interleukin‐1 and interleukin‐6 production by hepatic endothelial cells and macrophages , 1993, Journal of leukocyte biology.

[30]  D. Laskin,et al.  Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells , 1992, Hepatology.

[31]  W. Travis,et al.  Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. , 1992, Journal of immunology.

[32]  Y. Shiratori,et al.  Role of endotoxin‐responsive macrophages in hepatic injury , 1990, Hepatology.

[33]  F. Robertson,et al.  Activation of liver macrophages following phenobarbital treatment of rats , 1988, Hepatology.

[34]  D. Laskin,et al.  Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. , 1986, Toxicology and applied pharmacology.

[35]  D. Laskin,et al.  Accumulation of Activated Mononuclear Phagocytes in the Liver Following Lipopolysaccharide Treatment of Rats , 1986, Journal of leukocyte biology.

[36]  A. Al-Tuwaijri,et al.  Modification of galactosamine‐induced liver injury in rats by reticuloendothelial system stimulation or depression , 1981, Hepatology.

[37]  Mitsuru Sato,et al.  gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. , 2010, Biochimica et biophysica acta.

[38]  J. Fitz,et al.  Regulation of cellular ATP release. , 2007, Transactions of the American Clinical and Climatological Association.